Antigen design enhances the immunogenicity of Semliki Forest virus-based therapeutic human papillomavirus vaccines.

MLA

Ip, P. P., et al. “Antigen Design Enhances the Immunogenicity of Semliki Forest Virus-Based Therapeutic Human Papillomavirus Vaccines.” Gene Therapy, vol. 22, no. 7, July 2015, pp. 560–67. EBSCOhost, https://doi.org/10.1038/gt.2015.24.

APA

Ip, P. P., Boerma, A., Walczak, M., Oosterhuis, K., Haanen, J. B., Schumacher, T. N., Nijman, H. W., & Daemen, T. (2015). Antigen design enhances the immunogenicity of Semliki Forest virus-based therapeutic human papillomavirus vaccines. Gene Therapy, 22(7), 560–567. https://doi.org/10.1038/gt.2015.24

Chicago

Ip, P P, A Boerma, M Walczak, K Oosterhuis, J B Haanen, T N Schumacher, H W Nijman, and T Daemen. 2015. “Antigen Design Enhances the Immunogenicity of Semliki Forest Virus-Based Therapeutic Human Papillomavirus Vaccines.” Gene Therapy 22 (7): 560–67. doi:10.1038/gt.2015.24.